Clinical Handbook of Psychotropic Drugs

The Clinical Handbook of Psychotropic Drugs has become a standard
reference and working tool for psychiatrists, psychologists, physicians,
pharmacists, nurses, and other mental health professionals.
- Independent, unbiased
- Packed with unique, easy-to-read comparison charts and tables
(dosages, side effects, pharmacokinetics, interactions...) for a quick
overview of treatment options
- Succinct, bulleted information on all classes of medication: on- and
off-label indications, side effects, interactions, pharmacodynamics,
precautions in the young, the elderly, and pregnancy, nursing implications,
and much more - all you need to know for each class of drug
- Potential interactions and side effects summarized in comparison
charts
- With instantly recognizable icons and in full color throughout, allowing
you to find at a glance all the information you seek
- Clearly written patient information sheets available for download as
printable PDF files
This book is a must for everyone who needs an up-to-date, easy-touse,
comprehensive summary of all the most relevant information
about psychotropic drugs.

New in this edition:
- Third-generation antipsychotics with major additions and changes
- Pharmacogenomics fully revised
- ECT thoroughly revised and updated
- BLT / rTMS with extended references
- Extrapyramidal side effects chart extended
- Antidepressants vilazodone and vortioxetine with extended coverage
- New chart of agents under investigation for treatment of substance
use disorders
- Approved and off-label indications updated
- New unapproved treatments with significant updates, including
anti-inflammatories, hormones, and 5-HT3 antagonists, in depression,
dementia, schizophrenia, and anxiety disorders
- New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti)
and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant
(Belsomra)
- New formulations and tradenames include: Brisdelle (paroxetine
mesylate), Irenka